Articul8 AI unveils “A8 Essential” – a new GenAI product that enables enterprises to rapidly explore insights from their complex data to unlock value
YXT.com Implements Enterprise-Wide Learning Solution for Fortune 500 Infrastructure Leader, Advancing Digital Transformation
FloQast Strengthens Global Expansion with New Executive Appointment in EMEA
AlayaCare Selected by Bayshore HealthCare to Transform Home-Based Care in Canada
Press Release: Travl.App Addresses Missed Travel Opportunities with Innovative Savings Solutions
SUNFISH Part 2 study population includes broad range of ages and disease severities, representing a…
– Initial dose-escalation data from Phase 1 clinical trial for lead wholly owned CD47 checkpoint…
Daix (France), March 15, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
– Firdapse® Q4-20 Net Revenues of $31.0 Million, FY-20 Net Revenues of $119.1 Million –…
MIAMI, March 15, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ:LGVN) (“Longeveron” or the “Company”), a…
CAMBRIDGE, Mass., March 15, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (NASDAQ: RUBY) (“Rubius”), a…
Announced Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia Interim…
Agreement leverages Fulgent’s Next Generation Sequencing (“NGS”) capabilities for genomic sequencing to aid in ongoing…
FORT LAUDERDALE, Fla., March 15, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
Reports Net Revenues of $95.9 Million for the Three Months Ended December 31, 2020 RANCHO…
03_15_2021 Press Release Image Retail Display Box – Vitamin D3 Infused Tauri-Gum™ The Company’s Assembling of…
SAN CARLOS, Calif., March 15, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Total second quarter revenue of $31.5 million increased 62% year-over-year on continued recovery and expansion…
Apabetalone Inhibits SARS-CoV-2 Infection at Levels Comparable to Approved Antiviral CALGARY, Alberta, March 15, 2021…
MORRISTOWN, N.J., March 15, 2021 (GLOBE NEWSWIRE) — BioAegis Therapeutics Inc., a clinical stage, private…
Saga Pure ASA has on 15 March 2021 sold 2,284,280 shares in Vistin Pharma ASA,corresponding…
Tycoon Industrier AS has today 15 March 2021 purchased 784 280 shares in Vistin Pharma at NOK…
Stimulation of peripheral nerves warrants consideration early in the care continuum CLEVELAND, March 15, 2021…
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR…
CAMBRIDGE, Mass., March 15, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage…